XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.1
Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary Shares
Share capital and additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2020   $ 82,827 $ (243) $ (70,715) $ 11,869
Balance (in Shares) at Dec. 31, 2020 4,391,163        
Share based compensation expense   94 94
Share based compensation expense (in Shares) 7,188        
Exercise of options   119 119
Exercise of options (in Shares) 52,167        
Issuance of Ordinary Shares in connection with Prospectus Supplement   1,814 1,814
Issuance of Ordinary Shares in connection with Prospectus Supplement (in Shares) 800,000        
Net income   451 451
Balance at Dec. 31, 2021   84,854 (243) (70,264) 14,347
Balance (in Shares) at Dec. 31, 2021 5,250,518        
Share based compensation expense   241 (144) 97
Exercise of options   2 2
Exercise of options (in Shares) 1,000        
Issuance of Ordinary Shares in connection with Prospectus Supplement   912 912
Issuance of Ordinary Shares in connection with Prospectus Supplement (in Shares) 450,000        
Net income   1,276 1,276
Balance at Dec. 31, 2022   86,009 (243) (69,132) 16,634
Balance (in Shares) at Dec. 31, 2022 5,701,518        
Share based compensation expense   97 97
Exercise of options   103 103
Exercise of options (in Shares) 46,500        
Issuance of Ordinary Shares in connection with Prospectus Supplement  
Net income   2,005 2,005
Balance at Dec. 31, 2023   $ 86,209 $ (243) $ (67,127) $ 18,839
Balance (in Shares) at Dec. 31, 2023 5,748,018